Article Versions Notes

Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Vitale F, Cristiano L, Martellucci S, Marampon F, Mattei V, et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers. 2019; 11(3):359. https://doi.org/10.3390/cancers11030359

Gravina, Giovanni Luca, Andrea Mancini, Alessandro Colapietro, Simona Delle Monache, Roberta Sferra, Flora Vitale, Loredana Cristiano, Stefano Martellucci, Francesco Marampon, Vincenzo Mattei, and et al. 2019. "The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models" Cancers 11, no. 3: 359. https://doi.org/10.3390/cancers11030359

Gravina, G. L., Mancini, A., Colapietro, A., Delle Monache, S., Sferra, R., Vitale, F., Cristiano, L., Martellucci, S., Marampon, F., Mattei, V., Beirinckx, F., Pujuguet, P., Saniere, L., Lorenzon, G., van der Aar, E., & Festuccia, C. (2019). The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers, 11(3), 359. https://doi.org/10.3390/cancers11030359